A trial of IKT-148009 in untreated Parkinson's disease (H-52926)
Description
Content
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's disease
The purpose of this study is to evaluate safety and efficacy of IkT-148009 in people with untreated Parkinson’s Disease. IkT-148009 is an experimental drug, which means that the FDA has not approved it for the treatment of Parkinson’s disease or any other indication.
Contact
Phone 1: 713–798–5989
IRB: H-52926
Status:
Active
Created:
